1968
DOI: 10.1111/j.1749-6632.1968.tb15149.x
|View full text |Cite
|
Sign up to set email alerts
|

Regulation of Erythropoiesis. Xx. Kinetics of Red Cell Production*

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
22
0
8

Year Published

1970
1970
2013
2013

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 89 publications
(30 citation statements)
references
References 25 publications
0
22
0
8
Order By: Relevance
“…It is therefore possible that the slight elevation of HbF in peripheral blood of pregnant women is the reflection of stimulated erythropoiesis and release of erythroid cells at earlier maturational stages (28). Similar mechanisms may be in operation to account for the increased level of HbF observed in a number of pathological conditions such as leukemia and aplastic anemia.…”
Section: Methodsmentioning
confidence: 95%
“…It is therefore possible that the slight elevation of HbF in peripheral blood of pregnant women is the reflection of stimulated erythropoiesis and release of erythroid cells at earlier maturational stages (28). Similar mechanisms may be in operation to account for the increased level of HbF observed in a number of pathological conditions such as leukemia and aplastic anemia.…”
Section: Methodsmentioning
confidence: 95%
“…14,15 Over the past decade, several lines of evidence have indicated that erythropoietin and EPOR exhibit a widespread distribution among a variety of organs in addition to kidney. [15][16][17][18] A large body of additional studies has shown that erythropoietin protects cardiac function by increasing blood flow and preventing apoptosis in ischemia models.…”
Section: Discussionmentioning
confidence: 99%
“…14,15 Erythropoietin and its receptor, erythropoietin receptor (EPOR), are expressed in a variety of tissues, including the vascular system. 16 -18 Beside its role in erythropoiesis, increasing evidence suggests that erythropoietin exerts several extrahematopoietic protective effects for cardiovascular diseases.…”
Section: Clinical Perspective On P 1837mentioning
confidence: 99%
“…21 It has been suggested that human erythroblasts undergo an additional mitosis. 22 To explore this issue, we cultured sorted pure erythroblasts at each of the 5 developmental stages and examined their ability to proliferate. The representative growth curves of these cells showed that while proerythroblasts continued to proliferate for 4 days and expanded approximately 18 times during this period (from 0.4 3 10 6 to 7.4 3 10 6 ), orthochromatic erythroblasts were not able to divide at all ( Figure 4C).…”
Section: Mitotic Capacity Of Erythroblast Populations At Distinct Devmentioning
confidence: 99%